224 related articles for article (PubMed ID: 8134660)
1. Recommendations for African horse sickness vaccines for use in nonendemic areas.
House JA
Rev Elev Med Vet Pays Trop; 1993; 46(1-2):77-81. PubMed ID: 8134660
[TBL] [Abstract][Full Text] [Related]
2. Control and eradication of African horse sickness with vaccine.
Sánchez-Vizcaíno JM
Dev Biol (Basel); 2004; 119():255-8. PubMed ID: 15742636
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals.
von Teichman BF; Smit TK
Vaccine; 2008 Sep; 26(39):5014-21. PubMed ID: 18682269
[TBL] [Abstract][Full Text] [Related]
4. In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6.
von Teichman BF; Dungu B; Smit TK
Vaccine; 2010 Sep; 28(39):6505-17. PubMed ID: 20638456
[TBL] [Abstract][Full Text] [Related]
5. Current status of the diagnosis and control of African horse sickness.
Rodriguez M; Hooghuis H; Castaño M
Vet Res; 1993; 24(2):189-97. PubMed ID: 8343805
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of inactivated African horse sickness (AHS) vaccine formulated with different adjuvants.
van Rijn PA; Maris-Veldhuis MA; Grobler M; Wright IM; Erasmus BJ; Maartens LH; Potgieter CA
Vaccine; 2020 Oct; 38(45):7108-7117. PubMed ID: 32921506
[TBL] [Abstract][Full Text] [Related]
7. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
[TBL] [Abstract][Full Text] [Related]
8. African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform.
van Rijn PA; Maris-Veldhuis MA; Potgieter CA; van Gennip RGP
Vaccine; 2018 Apr; 36(15):1925-1933. PubMed ID: 29525278
[TBL] [Abstract][Full Text] [Related]
9. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
[TBL] [Abstract][Full Text] [Related]
10. Inactivated and adjuvanted vaccine for the control of the African horse sickness virus serotype 9 infection: evaluation of efficacy in horses and guinea-pig model.
Lelli R; Molini U; Ronchi GF; Rossi E; Franchi P; Ulisse S; Armillotta G; Capista S; Khaiseb S; Di Ventura M; Pini A
Vet Ital; 2013; 49(1):89-98. PubMed ID: 23564590
[TBL] [Abstract][Full Text] [Related]
11. Further studies on the efficacy of an inactivated African horse sickness serotype 4 vaccine.
House JA; Lombard M; Dubourget P; House C; Mebus CA
Vaccine; 1994 Feb; 12(2):142-4. PubMed ID: 8147096
[TBL] [Abstract][Full Text] [Related]
12. Serological response of foals to polyvalent and monovalent live-attenuated African horse sickness virus vaccines.
Crafford JE; Lourens CW; Smit TK; Gardner IA; MacLachlan NJ; Guthrie AJ
Vaccine; 2014 Jun; 32(29):3611-6. PubMed ID: 24814557
[TBL] [Abstract][Full Text] [Related]
13. The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.
Calvo-Pinilla E; Gubbins S; Mertens P; Ortego J; Castillo-Olivares J
Antiviral Res; 2018 Jun; 154():132-139. PubMed ID: 29678552
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic DIVA tests accompanying the Disabled Infectious Single Animal (DISA) vaccine platform for African horse sickness.
van Rijn PA; Maris-Veldhuis MA; Boonstra J; van Gennip RGP
Vaccine; 2018 Jun; 36(25):3584-3592. PubMed ID: 29759377
[TBL] [Abstract][Full Text] [Related]
15. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
Maree S; Paweska JT
J Virol Methods; 2005 Apr; 125(1):55-65. PubMed ID: 15737417
[TBL] [Abstract][Full Text] [Related]
16. Virus recovery rates for wild-type and live-attenuated vaccine strains of African horse sickness virus serotype 7 in orally infected South African Culicoides species.
Venter GJ; Paweska JT
Med Vet Entomol; 2007 Dec; 21(4):377-83. PubMed ID: 18092976
[TBL] [Abstract][Full Text] [Related]
17. Future international management of African horse sickness vaccines.
House JA
Arch Virol Suppl; 1998; 14():297-304. PubMed ID: 9785514
[TBL] [Abstract][Full Text] [Related]
18. [Use of the immunoenzyme test ELISA-NS3 to distinguish horses infected by African horsesickness virus from vaccinated horses].
Idrissi Bougrine S; Fassi Fihri O; el Harrak M; Fassi Fehri MM
Rev Sci Tech; 1999 Dec; 18(3):618-26. PubMed ID: 10588005
[TBL] [Abstract][Full Text] [Related]
19. Humoral antibody response of 10 horses after vaccination against African horse sickness with an inactivated vaccine containing all 9 serotypes in one injection.
Wernery U; Rodriguez M; Raghavan R; Syriac G; Miriam Thomas M S; Elizabeth SK; Federico Ronchi G; Muhammed R; Patteril NA; Joseph S
Equine Vet J; 2021 Jul; 53(4):826-833. PubMed ID: 33011979
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
